Clinical Trials
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
S0013
Evaluation of In Vitro Assays as Predictors of Clinical Outcome in Patients With Locally Advanced (Stage IIB-IVA)Cervical Carcinoma, Biologic
Research Committee(s)
Gynecologic Cancer
Activated
09-15-2000
Closed
11-15-2003
Closed
Phase
SWOG Clinical Trial Number
S9925
Lung Cancer Specimen Repository Protocol, Ancillary
Research Committee(s)
Lung Cancer
Activated
09-01-2000
Closed
03-15-2010
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S0008
Phase III Trial of High Dose Interferon Alpha-2b versus Cisplatin, Vinblastine, DTIC Plus IL-2 and Interferon in Patients with High Risk Melanoma
Research Committee(s)
Melanoma
Activated
08-01-2000
Closed
11-15-2007
Closed
Phase
Accrual
48%
SWOG Clinical Trial Number
S0010
A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-Cell Acute Lymphoblastic Leukemia (ALL)
Research Committee(s)
Leukemia
Activated
07-15-2000
Closed
03-15-2004
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S9920
A Phase III Randomized Study Comparing Busulfan – Total Body Irradiation Versus Cyclophosphamide – Total Body Irradiation Preparative Regimen in Patients with Advanced Myelodysplastic Syndrome (MDS) or MDS – Related Acute Myeloid Leukemia (AML) Undergoing HLA-Identical Sibling Peripheral Blood Stem Cell Transplantation, (A BMT Study)
Research Committee(s)
Leukemia
Activated
06-15-2000
Closed
10-15-2001
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
S9927
Randomized Trial of Post-Mastectomy Radiotherapy in Stage II Breast Cancer in Women With One to Three Positive Axillary Nodes, Phase III
Research Committee(s)
Breast Cancer
Activated
06-15-2000
Closed
06-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9923
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
08-01-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9924
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
06-01-2001
Closed
Phase
Accrual
3%
SWOG Clinical Trial Number
S9901
A Randomized Phase III Trial Comparing Early High Dose Chemotherapy and an Autologous Stem Cell Transplant to Conventional Dose ABVD Chemotherapy for Patients with Advanced Stage Poor Prognosis Hodgkin’s Disease as Defined by the International Prognostic Factors Project on Advanced Hodgkin’s Disease, Intergroup
Research Committee(s)
Lymphoma
Activated
04-15-2000
Closed
11-01-2001
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
S9922
A Phase III Trial of Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin (DCEP) and G-CSF With or Without Thalidomide (NSC #66847) as Salvage Therapy for Patients with Refractory Multiple Myeloma
Research Committee(s)
Myeloma
Activated
04-15-2000
Closed
11-01-2001
Closed
Phase
Accrual
56%
SWOG Clinical Trial Number
S9926
Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
Research Committee(s)
Sarcoma
Activated
04-15-2000
Closed
09-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0014
Evaluation of CHOP Plus Rituximab Plus Involved Field Radiotherapy for Stages I, IE, and Non-Bulky Stages II and IIE, CD20 Positive, High Risk Localized Aggressive Histologies of Non-Hodgkin’s Lymphoma, Phase II
Research Committee(s)
Lymphoma
Activated
04-01-2000
Closed
01-15-2002
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9917
L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High Grade Prostatic Intraepithelial Neoplasia
Activated
02-01-2000
Closed
11-01-2006
Closed
Phase
Accrual
29%
SWOG Clinical Trial Number
S9918
A Phase II Study of Daunomycin and Ara-C Given by Continuous IV Infusion with PSC-833 for Previously Untreated Non-M3 Acute Myeloid Leukemia (AML) in Patients of Age 56 or Older
Research Committee(s)
Leukemia
Activated
02-01-2000
Closed
03-15-2001
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
S9909
Positron Emission Tomography (PET) Imaging of Lung Cancer Response to Therapy in Patients Registered to S9900
Research Committee(s)
Lung Cancer
Activated
12-15-1999
Closed
05-15-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9902
Evaluation of the Combination of Docetaxel (Taxotere®)/ Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN), Phase II
Research Committee(s)
Head and Neck Cancer
Activated
11-15-1999
Closed
01-01-2001
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
S9900
A Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB(T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC).
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
07-15-2004
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S9914
Phase II Trial of Paclitaxel, Carboplatin and Topotecan with G-CSF in Untreated Patients with Extensive Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1999
Closed
06-15-2001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9916
Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-15-2003
Closed
Phase
Accrual
72%
SWOG Clinical Trial Number
S9921
Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy, Phase III.
Research Committee(s)
Genitourinary Cancer
Activated
10-15-1999
Closed
01-12-2007